OLGRAM
Olgram is a biotechnology company that develops marine molecules for the prevention and control of chronic bacterial infections.Olgram has an original positioning to address this critical need by developing new products that will target, for the first time, dormant bacteria (responsible for infectious relapses) with a new class of anti-infectious.
OLGRAM
Industry:
Biotechnology Medical
Founded:
2019-01-01
Address:
Bréhan-loudéac, Bretagne, France
Country:
France
Website Url:
http://www.olgram.com
Total Employee:
1+
Status:
Active
Contact:
+33 (0)6 75 69 31 30
Email Addresses:
[email protected]
Total Funding:
1.5 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Google Universal Analytics Mobile Optimized Drupal
Similar Organizations
Torus Biosystems
Torus Biosystems is a biotech startup that delivers molecular diagnostics for infectious diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Bpifrance
Bpifrance investment in Seed Round - Olgram
Official Site Inspections
http://www.olgram.com Semrush global rank: 5.46 M Semrush visits lastest month: 1.56 K
- Host name: cluster023.hosting.ovh.net
- IP address: 164.132.235.17
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris
More informations about "Olgram"
Olgram - Innovations from the sea to tackle infectious …
Olgram relies upon its international and complementary team of experts involved in research, drug development, pharmaceutical and industrial sucesses to develop the next immunotherapies. Learn more Jobs . Join an international …See details»
Olgram - Crunchbase Company Profile & Funding
Olgram is a biotechnology company that develops marine molecules for the prevention and control of chronic bacterial infections.Olgram has an original positioning to address this critical …See details»
Our vision - Olgram
Programs . Our pipeline: Delivering first-in-class immunotherapies of activation and regulation. We develop 2 different classes of therapeutic molecules in our 2 areas of expertise within our …See details»
Olgram Company Profile - Office Locations, Competitors, Revenue …
Olgram is a biotechnology company developing marine molecules and a proprietary screening platform to test and modify molecules. It develops NAIAP-OL20-01 and MIAMI-OL20-11 …See details»
Olgram SA – Swiss Biotech
The passion, determination and expertise of Olgram’s management and founders have led to many important developments in the field of medicine, driven by innovation and the improvement of the quality of life of patients around the …See details»
Olgram 2025 Company Profile: Valuation, Funding
Olgram General Information Description. Operator of a biotechnology company intended to fight immune deficiency post-traumatic brain injury and concussions. The company's technologies operate through two programs such as a new …See details»
History - Olgram
Olgram receive the support from the Britanny region via its Inno R&D collaborative. April 2021 . Olgram designed as Gold company by the European Investor Network. Dec 2022 . Winner of …See details»
Olgram - Products, Competitors, Financials, Employees, …
Olgram's industrial processes also contribute to carbon capture, aligning with their vision of saving lives while protecting the environment. It was founded in 2019 and is based in Behran, France. …See details»
Olgram - BioAlps
Olgram is a biotechnology company developing 2 programs : – a first in class molecule with the unique property to cure immune diseases with original target and mechanism of action allowing, in validated in vivo POC, to cure the …See details»
Olgram - Funding, Financials, Valuation & Investors - Crunchbase
Olgram is a biotechnology company that develops marine molecules for the prevention and control of chronic bacterial infections. New. Resources. ... How much funding has this …See details»
Olgram - VentureRadar
Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and …See details»
Olgram Company Information - Funding, Investors, and More
The company Olgram has raised a total of $3.6m in funding over 2 rounds. Key Insights: Olgram , April 2021: $1.8m; Olgram April 2021 Seed Funding Round: $1.8m; 2021. Olgram , April 2021 …See details»
Olgram Company Information - Funding, Investors, and More
Get information on funding, investors, industries, and more for Olgram. See Olgram company profile and funding data.See details»
Full List of Biotech Companies in Geneva (2025)
Feb 8, 2025 Geneva is also home to key global health institutions such as the Red Cross and the World Health Organization. Other important non-profit research institutions like Drugs for …See details»
MIAMI Program - Olgram
Olgram develops new molecules to cure the immune system deficiencies after traumatic brain injuries (TBI) that affects 25 million people worldwide every year. The World Health …See details»
OLGRAM - Atlanpole Biotherapies
Olgram is a private biotechnology company located in Britany, France that specializes in the development of molecules to fight against antibiotic resistance. Objectives and mission: The …See details»
Olgram | EU-Startups
Olgram is a biotechnology company that develops marine molecules for the prevention and control of chronic bacterial infections.Olgram has an original positioning to address this critical …See details»
Olgram Raises $1.77M for New Class of Antibiotics to Treat CF...
Apr 6, 2021 In a second phase, Olgram will target hospital-acquired infections in patients whose immune systems weaken (immunocompromised patients) after head trauma. “We are …See details»
Job offers - Olgram
Olgram biotech company Olgram biotech company: Olgram is a biotechnology company, that fights against antibiotic persistence by developing 2 programs: i) the discovery and …See details»
Olgram - healthtechinnovationdays6.com
Olgram HealthTech Innovation Days - 6th edition is an event organized by HealthTech For Care. HealthTech For Care is an endowment fund (non-for profit organization) whose primary …See details»